Cash BurnSustained negative operating and free cash flow indicate ongoing funding needs. Persistent cash burn forces reliance on equity raises or debt, diluting shareholders or increasing leverage, and limits the company's runway to commercialize, scale sales, and achieve durable profitability without external funding.
Lack Of ProfitabilityMaterial negative gross profit and operating losses show the company has not yet demonstrated operating leverage. With minimal revenue versus expenses, achieving sustainable margins will require significant revenue scale and cost discipline, a multi-quarter structural challenge for medtech commercialization.
Equity Erosion & Weak ReturnsDeclining equity and sharply negative ROE reflect persistent losses eroding shareholder value. Until net income turns persistently positive, returns will remain negative, constraining capital allocation options and investor confidence in the company’s ability to generate long-term shareholder value.